Entradas por csanchez

Rev Esp Quimioter 2010:23(1):43-47

Evaluation of pharmacodynamic target attainment with vancomycin treatment of bacteremia due to Staphylococcus aureus methicillin resistant J. A. LEPE, M. V. GIL-NAVARRO, M. D. SANTOS-RUBIO, J. BAUTISTA, J. AZNAR   Objective: The objective of the study is to evaluate the ability of standard vancomycin dosing strategies actually recommended to attain the pharmacodynamic target of an […]

Rev Esp Quimioter 2011:24(4):184-190

Bacteroides mobilizable and conjugative genetic elements: antibiotic resistance among clinical isolates           C. QUESADA-GÓMEZ               The conjugation is one of the most important mechanisms of horizontal gene transfer in prokaryotes, leading to genetic variation within a species and the acquisition of new traits, such as antibiotic resistance. Bacteroides is an obligate anaerobe of the colon and a […]

Rev Esp Quimioter 2011:24(4):191-197

Outpatient use of topical antimicrobials in Spain associated with other drugs (2005-2007)           P. MORI, D. MARTÍNEZ, J. BENEIT, E. PACHECO, J. GONZÁLEZ               Introduction: The consumption of antibiotics for systemic use has been well studied. However, data of topical use in our country are an anecdotal reference in the literature. Objective: To evaluate the outpatient use […]

Rev Esp Quimioter 2011:24(4):198-203

Treatment of chronic hepatitis C virus infection. A study of best predictors for response           N. OSPINA, J. L. RODRÍGUEZ, M. HERNÁNDEZ, C. GARCÍA, J. M. MARTÍN, E. REDONDO, L. OLIVIA, M. J. PENA               Objective: The aim of this study was evaluate the rate of sustained viral response (SVR) and the influence of different factors on […]

Rev Esp Quimioter 2011:24(4):204-208

Predictive factors for pneumonia in adults infected with the new pandemic A (H1H1) influenza virus           E. LERMA, L. SORLÍ, M. MONTERO, V. MAS, E. LÓPEZ, C. VILAPLANA, F. ÁLAVAREZ-LERMA, H. KNOBEL, J. P. HORCAJADA               Background: On April 2009 a new A (H1N1) influenza virus was identified with a higher incidence of severe outcome in younger […]

Rev Esp Quimioter 2011:24(4):209-211

Burkholderia cepacia bacteremia: a prospective analysis of 33 episodes           M. IBARGUREN, N. COBOS-TRIGUEROS, Á. SORIANO, J. A. MARTÍNEZ, Y. ZBOROMYRSKA, M. ALMELA, J. MENSA               Introduction: The aim of this study is to describe clinical characteristics and outcome of Burkholderia cepacia bacteraemia, susceptibility of the isolates and differences between cases from epidemic outbreaks and sporadic cases. […]

Rev Esp Quimioter 2011:24(4):213-216

Antimicrobial sensitivity of hippurate-negative Campylobacter and Helicobacter pullorum strains isolated from patients with diarrhea           P. BASCUÑANA, I. PENA, J. J. PICAZO, A. C. VELASCO                 C. jejuni as well as some hippurate-negative Campylobacter species and related diarrheagenic organisms, are the leading cause of gastroenteritis in our environment all throughout the year. The aim of the present […]

Rev Esp Quimioter 2011:24(4):217-222

Nosocomial infection following video-assisted thoracoscopic surgery            D. N. NAN, M. FERNÁNDEZ-AYALA, C. FARIÑAS-ÁLVAREZ, R. MONS, J. GONZÁLEZ-MACÍAS, M. C. FARIÑAS                   Objectives: To assess the incidence and risk factors for nosocomial infection after video-assisted thoracic surgery (VATS). Methods: Prospective cohort study of all consecutive patients who underwent VATS surgery during 20 months. Patients were visited on […]

Rev Esp Quimioter 2011:24(4):223-232

Antimicrobial susceptibility of Gram-negative organisms from intraabdominal infections and evolution of isolates with extended spectrum β-lactamases in the SMART study in Spain (2002-2010)            R. CANTÓN, E. LOZA, J. AZNAR, J. CALVO, E. CERCENADO, R. CISTERNA, F. GONZÁLEZ, J. L. LÓPEZ, C. RUBIO, A. I. SUÁREZ, F. TUBAU, I. WEBER, P. YUSTE, R. CAVANILLAS y grupo […]

Rev Esp Quimioter 2011:24(4):233-262

Consensus document on treatment of infections in diabetic foot              J.I. BLANES Y REPRESENTANTES DE LA ASOCIACIÓN ESPAÑOLA DE CIRUJANOS (AEC); SOCIEDAD ESPAÑOLA DE ANGIOLOGÍA Y CIRUGÍA VASCULAR Y (SEACV); SOCIEDAD ESPAÑOLA DE MEDICINA DE URGENCIAS Y EMERGENCIAS (SEMES); SOCIEDAD ESPAÑOLA MEDICINA INTERNA (SEMI); SOCIEDAD ESPAÑOLA DE MEDICINA INTENSIVA, CRÍTICA Y UNIDADES CORONARIAS (SEMICYUC) Y SOCIEDAD […]